Author

F. Aswad

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:genetic perturbation / CRISPR· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

A. A. A. Pezzulo· 1 shared D. Meyerholz· 1 shared J. Joseph· 1 shared J. Rebo· 1 shared J. Stumpff· 1 shared J. Zheng· 1 shared K. A. Queen· 1 shared K. Fisher· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. A. A. Pezzulo

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Identification of the KIF18A alpha-4 helix as a therapeutic target for chromosomally unstable tumor cells

K. Schutt, K. A. Queen, K. Fisher, O. Budington, W. Mao, W. Liu, Y. Xiao, F. Aswad, J. Joseph, J. Stumpff

This study identifies the KIF18A alpha-4 helix as a therapeutic target, showing that mutations or inhibitors targeting this region disrupt proliferation of chromosomally unstable tumor cells.

bioRxiv · Oct 16, 2023 · PreprintCancer Biology

Eicosanoid signaling as a therapeutic target in middle-aged mice with severe COVID-19

S. Perlman, L. Y. R. Wong, J. Zheng, K. Wilhelmsen, K. Li, M. E. Ortiz Bezara, N. J. Schnicker, A. A. A. Pezzulo, P. J. Szachowicz, K. Klumpp, F. Aswad, J. Rebo, S. Narumiya, M. Murakami, D. Meyerholz, , P. B. McCray

This study identifies the PLA2G2D-PGD2/DP1 pathway as a therapeutic target for severe COVID-19 in middle-aged mice, showing protection through DP1 antagonism.

bioRxiv · Apr 20, 2021 · PreprintMicrobiology